Academic Bibliography

Search 200 years of publications by Ghent University researchers.

dr. Sandra Van Lint

Faculty of Medicine and Health Sciences > Department of Internal Medicine and Pediatrics

ORCID iD: 0000-0001-9767-5386

Add to list
- Journal Article
- A1
- open access
Ferroptosis-armed dendritic cell vaccines for glioma immunotherapy

Mariia Saviuk (UGent) , Victoria D. Turubanova, Sara De Brée (UGent) , Sandra Van Lint (UGent) , Teresa Mendes Maia, Simon Devos (UGent) , Iuliia Efimova (UGent) , Julie Braet (UGent) , Lore Van Oudenhove, Gitta Boons, et al.

(2026) NATURE COMMUNICATIONS.
Add to list
- Conference Paper
- C3
Phase Ia study of MIDRIX4-LUNG, a tetravalent autologous dendritic cell immunotherapy, in patients with metastatic non-small cell lung cancer

D. Stevens, Joline Ingels (UGent) , Elisabeth Brabants (UGent) , Sandra Van Lint (UGent) , Celine Everaert (UGent) , Karin Weening (UGent) , Kelly Heyns (UGent) , S. Desmet, Pam Devreker (UGent) , Nele Lootens (UGent) , et al.

(2025) JOURNAL OF THORACIC ONCOLOGY. In Journal of Thoracic Oncology 20(3, Supplement 1). p.S38-S39
Add to list
- Journal Article
- A1
- open access
A co-culture model to study modulators of tumor immune evasion through scalable arrayed CRISPR-interference screens

Ramiro Martinez (UGent) , Chiara Finocchiaro, Louis Delhaye (UGent) , Fien Gysens, Jasper Anckaert (UGent) , Wim Trypsteen (UGent) , Maarten Versteven, Eva Lion, Sandra Van Lint (UGent) , Karim Vermaelen (UGent) , et al.

(2024) FRONTIERS IN IMMUNOLOGY. 15.
Add to list
- Journal Article
- A1
- open access
Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum

Joline Ingels (UGent) , Laurenz De Cock, Dieter Stevens (UGent) , Rupert Mayer (UGent) , Fabien Henri Thery (UGent) , Guillem Sanchez Sanchez, David Vermijlen, Karin Weening (UGent) , Saskia De Smet (UGent) , Nele Lootens (UGent) , et al.

(2024) CELL REPORTS MEDICINE. 5(5).
Add to list
- Journal Article
- A1
- open access
A bispecific Clec9A-PD-L1 targeted type I interferon profoundly reshapes the tumor microenvironment towards an antitumor state

Sandra Van Lint (UGent) , Alexander Van Parys (UGent) , Bram Van Den Eeckhout (UGent) , Niels Vandamme (UGent) , Stephane Plaisance, Annick Verhee (UGent) , Dominiek Catteeuw (UGent) , Elke Rogge (UGent) , Jennifer De Geest (UGent) , Nele Vanderroost (UGent) , et al.

(2023) MOLECULAR CANCER. 22(1).
Add to list
- Journal Article
- A1
- open access
Small-scale manufacturing of neoantigen-encoding messenger RNA for early-phase clinical trials

Joline Ingels (UGent) , Laurenz De Cock, Rupert Mayer (UGent) , Pam Devreker (UGent) , Karin Weening (UGent) , Kelly Heyns (UGent) , Nele Lootens (UGent) , Saskia De Smet (UGent) , Marieke Brusseel (UGent) , Stijn De Munter (UGent) , et al.

(2022) CYTOTHERAPY. 24(2). p.213-222
Add to list
- Journal Article
- A1
- open access
Dendritic cell-based immunotherapy in lung cancer

Dieter Stevens (UGent) , Joline Ingels (UGent) , Sandra Van Lint (UGent) , Bart Vandekerckhove (UGent) and Karim Vermaelen (UGent)

(2021) FRONTIERS IN IMMUNOLOGY. 11.
Add to list
- Journal Article
- A1
- open access
Targeting IFN activity to both B cells and plasmacytoid dendritic cells induces a robust tolerogenic response and protection against EAE

Anje Cauwels (UGent) , Sandra Van Lint (UGent) , Elke Rogge, Annick Verhee (UGent) , Bram Van Den Eeckhout (UGent) , Shengru Pang, Marco Prinz, Niko Kley, Gilles Uze and Jan Tavernier (UGent)

(2021) SCIENTIFIC REPORTS. 11(1).
Add to list
- Journal Article
- A1
- open access
Selective IL-1 activity on CD8+ T cells empowers antitumor immunity and synergizes with neovasculature-targeted TNF for full tumor eradication

Bram Van Den Eeckhout (UGent) , Leander Huyghe (UGent) , Sandra Van Lint (UGent) , Elianne Burg (UGent) , Stéphane Plaisance, Frank Peelman (UGent) , Anje Cauwels (UGent) , Gilles Uzé, Niko Kley, Sarah Gerlo (UGent) , et al.

(2021) JOURNAL FOR IMMUNOTHERAPY OF CANCER. 9(11).
Add to list
- Journal Article
- A1
- open access
mRNA in cancer immunotherapy : beyond a source of antigen

Lien Van Hoecke (UGent) , Rein Verbeke (UGent) , Heleen Dewitte (UGent) , Ine Lentacker (UGent) , Karim Vermaelen (UGent) , Karine Breckpot and Sandra Van Lint (UGent)

(2021) MOLECULAR CANCER. 20(1).

1
2
3
4
5

Next →